• Home
  • Media
  • Press Releases

Press Releases


Statement Regarding the Withdrawal of Dialon

On Monday, MOHAP issued a circular to medical zones, hospitals and pharmacies to withdraw diabetes medicine, Dialon 500mg, due to an issue with its solubility with the reference product. Dialon is the…
Oncology Market

Julphar Announces Entry into Oncology Market

- Agreement signed with Russia’s leading biotechnology company - Products used to treat range of cancers including breast cancer - Launch of medicines in UAE to improve access to cancer treatments…

Julphar Explores Opportunities in Uzbekistan

- UAE Pharma company attends leading forum in Tashkent   - ‘Country has great unrealized potential’ says company’s Intercontinental Region Director - Uzbekistan mooting plans…

Julphar Wraps Up Very Successful Participation at Regional Debut of Leading Global Pharma Event

- MENA pharma market set to top US$44 billion - Event attended by 250 exhibitors and 4,000 industry professionals from around the world Julphar, one of the largest pharmaceutical manufacturers in the…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.